Patent ID: 11957656
Assignee: LEVO THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 7:
8. The method of claim 1, wherein the method further comprises administering insulin, an insulin receptor agonist, ghrelin, a ghrelin receptor agonist, growth hormone-releasing hormone (GHRH), a GHRH receptor agonist, alpha-melanocyte stimulating hormone (alpha-MSH), an alpha-MSH receptor agonist, oxytocin, an oxytocin receptor agonist, orexin, an orexin receptor agonist, Brain-derived neurotrophic factor (BDNF), a BDNF receptor agonist, vasopressin, a vasopressin receptor agonist, Neuropeptide Y (NPY), an NPY receptor agonist, Agouti-related protein (AGRP), an AGRP receptor agonist, gonadotropin, a gonadotropin receptor against, or combinations thereof.